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Abstract : Mammary hamartoma is benign lesion and relatively rare. 17 cases of breast cancer associated with a 
hamartoma had been previously documented in the literature. We describe herein a case of noninvasive ductal 
carcinoma of the breast arising in hamartoma in a woman of 60’s. The discordance of images of the mass between 
mammogram and ultrasonogram can lead us to detect the carcinoma within the hamartoma in our case. J. Med. 
Invest. 67 : 368-371, August, 2020
Keywords : Breast cancer, Mammary hamartoma, Ductal carcinoma in situ
INTRODUCTION
 
Mammary hamartoma is commonly shown an encapsulated 
mass containing fat and parenchymal densities in mammogram 
or ultrasonogram. Hamartoma is a distinct subtype of benign 
tumor, forming circumscribed or lobulated mass consisting of 
a mixture of fat tissue and normal parenchyma with fibrous 
stroma. Hamartomas are essentially disorganized overgrowth of 
normal mammary tissue, and they are named fibroadenolipoma 
or adenolipofibroma in other word. Stromal element of hamarto-
ma uncommonly shows myoid change or muscle differentiation 
(1). Coexistence of breast carcinoma with a mammary ham-
artoma is extremely rare. Cases with hamartoma associated 
carcinoma had been reported in the literature (2-6). We describe 
a case of hamartoma from which ductal carcinoma in situ had 
arisen. In our case, ductal carcinoma in situ had developed 
within hamartoma and had limited to the region of hamarto-
ma. The discordance between mammogram or ultrasonogram 
and CT image of the lesion had led us to do core needle biopsy 
of the lesion, and we were finally able to detect breast cancer in 
hamartoma. The report emphasizes the importance of adequate 
imaging analyses or tissue sampling of mammary hamartoma. 
CASE REPORT
A woman of 60’s had jointed to mass screening for breast 
cancer every other year. She is healthy except undergoing med-
ication for hypertension. Her family history of breast pathology 
or hereditary disease is absent. As she was pointed out an 
abnormal shadow in her left mammography, she visited to the 
outpatient clinic for further examination. Ultrasonography and 
mammography were routinely done. Mammogram revealed 
an irregular and lobulated dense shadow in the upper-outer 
quadrant of left breast (Fig. 1a).  Ultrasonogram revealed an 
oval tumor with heterogeneous internal echoes, representing 
the hamartoma (Fig. 1b). A physical finding revealed a firm, 
ill-defined, mobile, oval tumor with a smooth surface measuring 
3 × 2 cm at the upper-outer quadrant of the left breast and no 
swelling of axillary lymph nodes. As the images of the lesion are 
quietly different between ultrasonogram and mammogram, the 
patient was examined MRI.
A T2-weighted MRI image revealed no emphasized mass. 
A T1-weighted dynamic MRI revealed irregular and lobular 
mass, measuring 15 mm and being shaped like mammographic 
image (Fig. 1c). Dynamic curve of MRI imaging showed steep 
and constant pattern. From MRI image the lesion was thought 
to be malignancy, such as scirrhous type of ductal carcinoma or 
noninvasive carcinoma. 
Core needle biopsy using ultrasonography was performed. 
Two specimens were collected. Microscopically, cancer cells 
which were medium-sized to large nuclei filled many ducts and 
proliferated in flat, solid and comedo pattern (Fig. 2a and 2b). 
Diagnosis of the lesion was ductal carcinoma in situ of the breast. 
Preoperative CT study showed the lesion in her left breast, be 
emphasized lobular shadow within an oval mass (Fig. 1d). It 
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Fig 1a.　Mammogram revealed an irregular and lobulated dense 
shadow (arrow) in the upper-outer quadrant of left breast.
Fig 1b.　Ultrasonogram revealed an oval tumor with heterogeneous 
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might be thought that lobular-shaped malignant lesion had ex-
tended within the circumscribed mass. 
The patient underwent a partial glandectomy and also sen-
tinel nodes biopsy. No metastasis to a sentinel lymph node was 
proven by OSNA (One-step nucleic acid amplification) assay for 
intra-operative detection of lymph node metastasis. The lesion 
was resected with surrounding normal tissue. The specimen of 
the breast was fixed in buffered formalin, and it cut into eleven 
slices having 6 mm width. In the 7th slice, capsuled yellowish 
mass in which grey and slightly firm area was observed in the 
mass was collected (Fig. 3). Postoperatively, the patient has been 
doing well for several months.
Pathology 
Microscopically, Hamartoma composed of mature fat tissue 
with scattered mammary ducts and lobules with clear encap-
sulation by delicate fibrous tissue included ductal carcinoma in 
situ inside (Fig. 4a). The cancer cells have high grade nuclei with 
central necrosis (Fig. 4b). The spreading of cancer cell was 13 × 4 
mm, and hamartoma was 22 × 7 mm in size.
1c 1d
Fig 1c.　T1-weighted dynamic MRI revealed irregular and lobular 
mass, measuring 15mm and being shaped like mammographic image.
Fig 1d.　Preoperative CT study showed the lesion in her left breast, 
be emphasized lobular shadow within an oval mass (arrow).
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Fig 2a.　CNB specimen (low power field) : Cancer cells filled many 
ducts showing solid and partially comedo pattern.
Fig 2b.　High power field of boxed area of Figure 2a.
Fig 3.　Cutsurface of the tumor : In the 7th slice, capsuled mass was 
collected in which grey and slightly firm area (arrow) was observed.
Fig 4a.　Low power magnification : Mass including ductal carcinoma 
in situ inside was encapsulated by delicate fibrous tissue.
Fig 4b.　High power magnification : Cancer cells have high grade 
nuclei with central necrosis.
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Immunohistochemistry
Immunohistochemically, the cancer cells were both negative 
for estrogen and progesterone receptors, and human epidermal 
growth factor receptor type 2 (HER2/neu) protein expression 
was also negative. Some parts of cancer cells show immunore-
activity for epidermal growth factor receptor (EGFR) with cell 
membrane staining pattern, and they were negative for CK5/6. 
The carcinoma was considered as basal cell type carcinoma.
DISCUSSION
The first description of mammary hamartoma had been 
written by Hogeman and Ostberg in their report in 1968 (7). 
Mammary hamartoma is circumscribed lesion composed of 
disorganized overgrowth of normal breast tissues, and showing 
various composition of ductal and lobular epithelium and stro-
mal elements. Hamartoma is often named as fibroadenolipoma 
or adenolipofibroma. The pathogenesis of the development of 
mammary hamartoma is not fully clear. Sevim and Kocaasy 
et al. reported a clinicopathologic analysis of 27 cases of ham-
artoma including one myoid hamartom, and mentioned the 
mean age and tumor size of them was 41.8 years and 3.9 cm, 
respectively, and described that breast hamartoma approxi-
mately accounts for 5% of all benign breast lesion (8).  Mammary 
hamartomas have a typical area of radiolucent and smooth edges 
in mammography where fat and various amounts of fibrous and 
adenomatous tissues were shown. Although radiologic feature 
is characteristic, Helvie et al. reported that 29% of the tumors 
in their study could not be detected on mammography (9). Typ-
ical ultasonogram of hamartoma showed sonolucent fat and a 
heterogenous internal echoes. Images of several diagnostic pro-
cedure of hamartoma are reflected their pathologic structures. 
Although pathologic diagnosis and treatment are completely able 
to make by excisional biopsy of the lesion, pathologic diagnosis 
cannot be always done by ultrasonograpy-guided core needle 
biopsy because of above mentioned internal texture of hamar-
toma. Herbert et al. reported immunohistochemical studies of 
24 breast hamartoma cases, in which all cases showed estrogen 
and progesterone receptors positivity in epithelial cells as well 
as in the stromal cells and no HER2/neu positivity were noted 
in these cases (10). Breast cancer associated with hamartoma 
is rare. Mendoiola et al. had described the first case report of a 
malignant lesion associated with hamartoma in 1982 (2). Nami 
et al. had reported 15 cases with coexistence of breast cancer 
and hamartoma (11) , and after the report Kai and Fukai were 
described a new case of carcinoma arising in mammary hamar-
toma in 2012 (12) and 2018 (13), respectively. Among the 17 cases 
past, 13 cases had carcinomas inside of the hamartoma. Cases 
involving both the hamartoma and adjacent normal breast tis-
sue are difficult to judge whether carcinoma arose in hamarto-
ma or carcinoma invaded to hamartoma. Our case was believed 
that carcinoma had arisen in hamartoma because carcinoma in 
situ completely had located within the encapsulated hamartoma. 
Among the past 17 cases, types of carcinoma associated with 
hamartoma are 1 combination of lobular and ductal, 1 mucinous, 
4 lobular and 11 ductal, and cases with noninvasive carcinoma 
associated are only 3 cases. And among them, molecular sub-
type of cancer was indicated in only two cases, that is, one (12) 
showed both negative for estrogen and progesterone receptors, 
and HER2/neu negative same as our case, and the other (13) 
showed estrogen receptor weakly positive, progesterone receptor 
negative, and HER2/neu positive. Early detection of a minimal 
malignant change in the hamartoma is an important point. 
Nami et al. descried that cluster of microcalcifications, pleomor-
phic microcacifications and spiculated masses were typical sign 
for coexistence of breast cancer in hamartoma (11). Sclerosing 
adenosis often shows architectural distortion and is recently well 
known as the lesion of developing breast cancer (14) . Fukai et al. 
reported a case in which ductal carcinoma in situ arose in scle-
rosing adenosis encapsulated by a hamartoma (13). It is import-
ant to perform periodical observation even if the prior diagnosis 
was benign hamartoma, and revelation the discordance of the 
lesion in each image, such as mammography, ultrasonography 
or MRI is also important to discover malignancies. In our case, 
image of lesion by mammography or MRI was differ from that by 
ultrasonography. Cowden syndrome is a disorder condition char-
acterized by multiple noncancerous, tumor-like growths called 
hamartomas and an increased risk of developing breast cancer, 
thyroid cancer or GI tract cancers and it thought to related mu-
tations in the PTEN gene (15). Although genetic analysis was 
not done in our case, breast cancer occurred in the case revealed 
basal cell like cancer. Although there are no reports discussed 
the genetic mechanism of mammary hamartoma, it may exist a 
certain mechanism of carcinogenesis related gene abnormality 
with occurring carcinoma in hamartoma. Genetic abnormalities 
of carcinomas in hamartoma should be analyzed in future.
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